Company overview
Quantabio provides advanced DNA and RNA amplification reagents for PCR, qPCR, RT-PCR, and NGS applications in life sciences and pharmaceutical research. Their proprietary ToughMix and qScript technologies deliver robust performance against PCR inhibitors, supporting pathogen detection, infectious disease assays, and library preparation for Illumina platforms. Products like UltraPlex 1-Step ToughMix enhance CDC protocols for respiratory disease detection, including COVID-19 and influenza.
Quantabio is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include quantabio, pcr reagents, qpcr master mix, ngs library prep, pathogen detection, toughmix.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.quantabio.com
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- quantabio, pcr reagents, qpcr master mix, ngs library prep, pathogen detection, toughmix, qscript
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What molecular biology reagents does Quantabio offer?
- Quantabio offers ToughMix reagents for PCR/qPCR, qScript reverse transcriptase kits for RT-PCR/cDNA synthesis, UltraPlex 1-Step ToughMix for multiplex assays, and NGS library prep solutions for Illumina platforms.
- Are Quantabio reagents suitable for pathogen detection and clinical labs?
- Yes, their reagents are used in thousands of clinical-translational and public health labs for sensitive pathogen detection in infectious disease assays, including CDC protocols for COVID-19 and influenza differentiation.
- What makes Quantabio products robust for challenging samples?
- Proprietary ToughMix and eQo technologies overcome PCR inhibitors, provide high fidelity, broad dynamic range, and reliable amplification for demanding molecular testing applications.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
